Tuesday, January 19, 2021

Abbott Launches Revolutionary FreeStyle® Libre System in India Providing Real-time Continuous Glucose Monitoring for People with Diabetes

Must read

Friends and family try to unravel this mystery in this teaser video of Amazon Prime Video’s The Family Man

MUMBAI, 13 January 2021. Amazon Prime Video today dropped a teaser video of the new season of the much-awaited...

&PrivéHD Presents The Academy Award-Winning Rags To Riches Story ‘Slumdog Millionaire’ As Part Of Privé Collection

Mumbai, January 13, 202. Winner of 8 Academy Awards®, including Best Picture of the Year and Best Director and a stellar cast...


Mumbai, 13 January 2021.  Accelerating its efforts to increase access to high-quality entertainment for every Indian, Amazon today introduced...

“I enjoy playing characters with multiple shades and Tandav gave me an opportunity to portray exactly that,” Saif Ali Khan

Since the trailer launch of Tandav, people have been excited to watch the show. How excited are you for the show’s release?

Bangalore, November 03, 2020.

Abbott, the global healthcare leader, announced today that the FreeStyle® Libre system, the world’s leading2 continuous glucose monitoring (CGM) technology, is now available for adults and children (above the age of four) living with diabetes in India and women with gestational diabetes (diabetes during pregnancy), offering them the choice to check glucose levels anytime and anywhere, ultimately improving glucose control3.

The FreeStyle Libre sensor measures glucose every minute in interstitial fluid through a small (5.5mm long) filament that is inserted just under the skin and held in place with a small adhesive pad. A quick scan of the sensor with a reader provides a real-time glucose reading on demand and a complete picture of a person’s glucose levels, without the need of painful, routine fingersticks or daily calibration, enabling meaningful lifestyle and therapy interventions.

FreeStyle Libre is designed for users to be able to check their glucose readings much more simply and frequently, and data show that higher scanning frequency of the technology has been shown to significantly improve time in optimal glucose range.

“Abbott’s revolutionary technology has changed the way millions of people manage diabetes globally and we are excited to bring this life changing technology to India,” said KalyanSattaru, general manager of the diabetes care business at Abbott. “People with diabetes are at the centre of Abbott’s innovation. We are happy to launch FreeStyle Libre in India that gives millions of Indians access to to high-quality, accurate and pain-free diabetes technology for continuous glucose monitoring. This helps people make more informed health decisions allowing them to live fuller lives.” 

India has the second largest diabetes population in the world, estimated to cross 100 million in the next decade*. Healthcare providers are continuously upgrading guidelines of care and nutrition advice to ensure the condition is managed to avoid diabetes-related complications. Multiple international and national professional medical bodies have recommended CGM use for people with diabetes to target improved clinical outcomes including Indian professional bodies such as Diabetes India and The Research Society for the Study of Diabetes in India (RSSDI).

RSSDI in its published recommendations4 in 2017 quotes that technology in diabetes management may be used in patients for better outcomes and to minimize complications. Evidence suggests that continuous glucose monitoring system can influence patients for diabetes self-care practices, which in turn results in glycemic control enhancement over a wide range of baseline therapies.

Dr Banshi Saboo, President, and lead member of the CGM panel at RSSDI said, “Monitoring glucose levels is a pre-requisite to ensure optimum glycaemic control. While glucometers are handy portable devices that help detect the single point-in-time capillary glucose, CGM devices provide complete visibility of the 24×7 glycaemic profile of the patient with diabetes up to 14 days. This technology helps fulfil an unmet need in diabetes helping patients make better choices in diet and exercise. In India, food has a social, cultural and emotional connect which leads to unrestricted diet despite doctor recommendations. While medication can help, people with diabetes must have a disciplined approach to managing the condition. In the current COVID environment, with reduced access to doctors and specialists, CGM empowers patients with actionable insights at hand that helps in remotely managing their glucose levels.”

Clinical trials and real-world data show that users of the FreeStyle Libre system have improved glucose control3, decreased time in hyperglycemia5 and hypoglycemia6 as well as reduced hospitalizations7, HbA1C8 levels (average glucose levels over three months), and improved quality of life. Greater time in range (TIR) has been linked to more stable glucose control, which could lead to fewer complications.

A lower TIR9 has been found associated with increased risk of progression to retinopathy and nephropathy by 64% and 40% respectively. Another recently released study10 demonstrates association of lower TIR with increased cardiovascular risk. With glucose levels under control, patients with diabetes as well as their treating HCPs can deal with their existing and potential complications in diabetes better.

Since its introduction in 2014, the FreeStyle Libre portfolio has revolutionized the way diabetes is managed globally by more than 2.5 million users in more than 50 countries8

More articles

Latest article

Manipal Institute of Technology students bag 1st prize at the “TechFest”

Manipal , January 18, 2021.  Students of Manipal Institute of Technology , MAHE bag first prize in the “Tech...

Padharo Mhare Des, Digital Covid Relief Concert Series to support folk artists dons a new avataar for Episode 3: Makar Sankranti Mela

Jaipur 18 January,2021. Makar Sakranti Mela Episode by Padharo Mhare Des, a Digital COVID Relief Concert Series initiated to...

नारायणा हॉस्पिटल, जयपुर में 73 वर्षीय सर्जन को दी गई कोविड वैक्सीन, डॉक्टरों व स्वास्थ्यकर्मियों के साथ किया गया आगाज़

Jaipur, January 2021. कोविड महामारी के इस दौर में वैक्सीन का यह पहला चरण अब तक की सबसे बड़ी...

Duroflex collaborates with actor Pratik Gandhi to talk about the importance of buying a trusted branded mattress for better sleep

National, January 18, 2021. Sleeping on a mattress that is scientifically designed to support your body and give a...

Tata Motors partners with India’s leading banks and NBFCs to offer the best financial assistance

Mumbai, January 18, 2021. Tata Motors, India’s largest commercial vehicle manufacturer, has entered into partnerships with the country’s leading...
Live Updates COVID-19 CASES